logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet

New agenda of the Aemps: management by objectives and supply plan

Source: Redaccionmedica.com
The Spanish Agency of Medicines and Health Products has presented its Strategic Plan 2019-2022 that includes a total of 11 measures that aim to face the challenges and strengthen the entity during the next four years. Specifically, the Aemps has defined five strategic objectives to achieve through this plan.
The 11 measures developed by the Management Board of the Aemps include a people plan, management plan by objectives, implementation of the Office of Innovation and Knowledge on Drugs, plan of information systems, external communication, transfer of knowledge to the EAMI Network, for internal knowledge management, improvement of the interdepartmental processes, international positioning, supply guarantees for medicines and another for strengthening institutional coordination.
These plans have different strategic approaches that go through optimizing the template; manage quality; improve efficiency; develop critical resources and capabilities; social impact, transparency and communication; improve the positioning of the Aemps; develop critical resources and capabilities; and improve user satisfaction and simplify processes.

Strategic objectives

To develop this plan, the Aemps has defined five strategic objectives. The first one is focused on providing guarantees, that is, guaranteeing to the public the quality, safety, efficacy, availability and information of medicines and health products, as well as the quality and safety of cosmetics and personal care products. . This line is framed by plan number 10, which refers to the supply of medicines.
Second, there is customer orientation. In this case, the Aemps aims to increase transparency, accessibility and user satisfaction. The third objective refers to the social impact, that is, to create value for society, Aemps being recognized as a national and international reference by interest groups, and promoting research.
Another strategy is efficiency, thus improving economic and organizational management. At this point, the agency includes workload management, simplifying operational processes, budget management, improving competitiveness and costs of activities. And, finally, the development of capabilities, which involves improving the resources of the Aemps through the development of people, technology and strategic alliances.

In Distefar we support this initiative of Aemps whose objective is to face the challenges and strengthen the entity during the next four years

Related entries

21 October, 2025

The geopolitical context presents Spain with a great opportunity to attract investment in the biopharmaceutical sector.


Leer más
14 October, 2025

“Spain has a great opportunity in the biopharmaceutical sector, but it must review its policies to maintain and increase its potential and attract investment in R&D and in industrial and digital assets.”


Leer más
7 October, 2025

Spain consolidates its leadership in clinical trials with new guidelines promoting innovation, digitalisation and sustainability in hospital pharmacy


Leer más

Recent Posts

  • The geopolitical context presents Spain with a great opportunity to attract investment in the biopharmaceutical sector.
  • “Spain has a great opportunity in the biopharmaceutical sector, but it must review its policies to maintain and increase its potential and attract investment in R&D and in industrial and digital assets.”
  • Spain consolidates its leadership in clinical trials with new guidelines promoting innovation, digitalisation and sustainability in hospital pharmacy
  • Innovation and data at the service of clinical research
  • Spain, European leader in clinical trials against cancer thanks to the agility and ‘atomisation’ of research groups

Contacta con nosotros


Tfno: +34 955.77.67.67
Fax: +34 955.77.65.56
info@distefar.net


Distefar del Sur
Sede Central

Distefar del Sur S.L.
Av. Umbrete, 58,
41110 Bollullos de la Mitación, Sevilla

Sede Madrid

Calle de Zurbano, 45, 28010 Madrid

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

MADRID DELEGATION

+34 674 575 115
28010 Madrid

Links of interest

  • Legal warning
  • Privacy policy
  • Cookies policy
  • Contact

© 2025 Distefar del Sur SL. All rights reserved. agencianodo.com

  • Contact
  • Private Zone
  • Español
  • English

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.